RxDoctor Payments Data

Phillip Tafoya, MD

Internal Medicine · Temecula, CANPI 1073509469

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 20th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$620,969
Medicare patients
524
Services billed
5,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase28$222,945
EliquisApixaban43$22,607
XareltoRivaroxaban12$13,311
JanuviaSitagliptin Phosphate12$4,537
VascepaIcosapent Ethyl11$3,481
Levothyroxine Sodium164$1,518
Atorvastatin Calcium176$1,386
Megestrol Acetate23$1,352
Travoprost11$1,306
Albuterol Sulfate HfaAlbuterol Sulfate32$1,241
Tamsulosin Hcl91$1,094
Levetiracetam44$818
Gabapentin55$786
Quetiapine Fumarate48$628
Pantoprazole Sodium47$599

Paid to pharmacies, not to this prescriber.

Other internal medicine in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →